Immunovant reports Q4 and fiscal year 2026 financial results
Filed May 20, 2026 · Period ending May 20, 2026 · ~1 min read
2 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade IMVT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 25, 2026 4:13 AM